中盈盛達融資擔保(01543.HK):2024年權益股東應占利潤增至4218萬元 末期息每股0.019元
格隆匯3月27日丨中盈盛達融資擔保(01543.HK)發佈公吿,截至2024年12月31日止年度,總收益約為人民幣3.59億元(包括收益約人民幣3.45億元及其他收益約人民幣1424萬元),較去年減少約7.60%;年內利潤及淨利潤率分別約為人民幣4282百萬元及12.42%;税前利潤約為人民幣6685萬元,較去年減少約11.23%;公司權益股東應占年內利潤約為人民幣4218萬元,較去年增加約9.84%。董事會建議派發年度末期股息每股人民幣0.019元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.